Abstract | PURPOSE: EXPERIMENTAL DESIGN:
Aromatase, sulfatase, and 17beta-HSD1 mRNA levels in tumor tissues (n = 181) and normal breast tissues (n = 34) were examined by a quantitative, real-time PCR assay and compared with various clinicopathological factors as well as prognosis. RESULTS: The sulfatase mRNA levels, but not the aromataseor 17beta-HSD1 mRNA levels, were significantly associated with lymph node metastases (P < 0.005), histological grade III (P < 0.001), and poor prognosis (P < 0.005). The association between the sulfatase mRNA and poor prognosis was found to be significant (P < 0.001) only in patients with estrogen receptor (ER)-positive tumors but not in ER negative tumors. In ER-positive tumors, the sulfatase mRNA levels was a significant prognostic factor independent of the lymph node status and histological grade by multivariate analysis. CONCLUSIONS: The sulfatase mRNA levels can serve as a significant, independent prognostic factor only in ER-positive tumors. It is speculated that the up-regulation of sulfatase mRNA levels leads to a high intratumoral estrogen concentration and, thus, an enhanced stimulation of tumor growth through ERs.
|
Authors | Yasuo Miyoshi, Akiko Ando, Seiichi Hasegawa, Makoto Ishitobi, Tetsuya Taguchi, Yasuhiro Tamaki, Shinzaburo Noguchi |
Journal | Clinical cancer research : an official journal of the American Association for Cancer Research
(Clin Cancer Res)
Vol. 9
Issue 6
Pg. 2288-93
(Jun 2003)
ISSN: 1078-0432 [Print] United States |
PMID | 12796397
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- RNA, Messenger
- Receptors, Estrogen
- 17-Hydroxysteroid Dehydrogenases
- Aromatase
- Steryl-Sulfatase
|
Topics |
- 17-Hydroxysteroid Dehydrogenases
(genetics)
- Aromatase
(genetics)
- Breast Neoplasms
(enzymology, mortality, pathology)
- Disease-Free Survival
- Female
- Humans
- Multivariate Analysis
- Prognosis
- RNA, Messenger
(analysis)
- Receptors, Estrogen
(analysis)
- Steryl-Sulfatase
(genetics)
|